dELiA*s Inc./ US2469111015 /
4/16/2019 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.0000USD | - | 100 Turnover: - |
-Bid Size: - | -Ask Size: - | 0.0000 | 0.0000 |
GlobeNewswire
2/21
Third Edition of the Mexico Open at Vidanta, the Top Social and Sporting Event in Latin America, Lau...
Newsfile Corp
2/14
Brown University Club of Greater Miami Hosts Book Talk with Frank Altman, Author of "A New Capitalis...
GlobeNewswire
11/7/2023
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Trea...
GlobeNewswire
11/2/2023
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the ...
GlobeNewswire
9/11/2023
Media Advisory: Gary White and Matt Damon to join CEOs and global leaders at UN Global Compact Leade...
GlobeNewswire
3/29/2022
HOUSING WORKS & FOUNDING CHAIR JAMES HUNIFORD ANNOUNCE LINEUP OF TOP INTERIOR DESIGNERS FOR ANNUAL D...
GlobeNewswire
3/23/2022
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targ...
GlobeNewswire
12/17/2021
Scopus BioPharma Issues Open Letter to Stockholders Detailing Morris Laster’s Campaign Against the C...
GlobeNewswire
12/7/2021
Scopus BioPharma Sends Letter Urging Stockholders to Vote “FOR ALL” of the Company’s Director Nomine...
GlobeNewswire
11/22/2021
Scopus BioPharma Announces $9.75 Million Private Placement Priced At-The-Market
GlobeNewswire
10/5/2021
Federal Court Ruling Upholding Habitat Conservation Plan on Tejon Ranch Stands
GlobeNewswire
10/1/2021
Scopus BioPharma to Present at MicroCap Rodeo’s Fall Harvest Best Ideas Conference